Generic Version of Esbriet Available in the US.
The astronomical costs of the two FDA-approved antifibrotic medications is a popular topic of conversation among our forum community, and for good reason. Without adequate coverage, the cost of these drugs are prohibitive for some patients living with idiopathic pulmonary fibrosis (IPF) to access. Sadly, anti-fibrotic medications, including Esbriet, are the only thing proven to slow down the progression of this cruel and debilitating lung disease.
For those of you living in the US, a generic version of Esbriet is now available through Sandoz. You can read more about it HERE, but something important to note is the $0 co-pay option for eligible patients.
For those of you currently on Esbriet but paying for the drug out of pocket, will you consider looking into this new generic version of the drug? Why or why not?
Log in to reply.